Skip to content

Contact +44 (0) 20 7060 7474 email us

Search Results


The product title you are looking for is no longer available. Other similar products that may interest you are listed below:

Refine your Search

Results for 'Reboxetine: Pipeline™ Selector'

Title Publication Date Price Relevance
Reboxetine
Pipeline Developer
Ongoing £3360 100 %
Reboxetine: Core Country Coverage
Pipeline Selector
Ongoing £260 96 %
Reboxetine: Extended Country Coverage
Pipeline Selector
Ongoing £610 96 %
Pfizer Prospects to 2010
Pipeline, Products,Performance,Potential
September 2007 £595 35 %
Stakeholder Opinions: Fibromyalgia
Potentially lucrative market soon to become reality
May 2007 £2005 33.25 %
Pipeline Insight: Neuropathic Pain
Emerging Drugs Fail To Capitalize In Lucrative Market
September 2007 £740 32.55 %
Stakeholder Insight: Major Depressive Disorder
Duloxetine - Fulfilling An Unmet Need?
March 2006 £8695 23.1 %